Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-051407

Director sold 2,375 shares at $18.06 ($42,893)

From the SEC's structured data for this filing

Trades in this filing

Ajer Jeffrey Robert · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-09-30 Sale : show line 1 in the form −2,375 $18.06 $42,893 22,375 D
Open-market sales · 2,375 sh · avg $18.06 · $42,893
Loading xslF345X03/doc4.xml…